Autotelic Bio is researching and developing innovative new drugs with a sense of duty to
improve the quality of life for patients around the world.
Autotelic Bio is doing our best to improve patients’ quality of life through innovative
new drug development.
Autotelic Bio aims to develop undruggable-target anti-cancer drugs to improve the effectiveness and reduce the side effects of existing cancer therapies, providing innovative treatment alternatives for cancer patients.
01
Innovation
We possess ASO platform technology for developing undruggable target
02
Joint Growth
03
Transparency